ASX - Delayed Quote AUD

Microba Life Sciences Limited (MAP.AX)

0.1700

+0.0050

+(3.03%)

At close: May 9 at 1:10:27 PM GMT+10

Key Events

Advanced Chart

Loading Chart for MAP.AX

Previous Close 0.1650
Open 0.1620
Bid 0.1650 x --
Ask 0.1850 x --
Day's Range 0.1620 - 0.1700
52 Week Range 0.1450 - 0.3250
Volume 71,033
Avg. Volume 190,218
Market Cap (intraday) 76.135M
Beta (5Y Monthly) 2.59
PE Ratio (TTM) --
EPS (TTM) -0.0300
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 0.29

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore, a diagnostics under the brand Co-Biome and MetaXplore; non-diagnostic personal and research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel disease, and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.

microba.com

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Diagnostics & Research

Industry

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

MAP.AX

12.82%

S&P/ASX 200 [XJO] (^AXJO)

0.88%

1-Year Return

MAP.AX

2.86%

S&P/ASX 200 [XJO] (^AXJO)

6.60%

3-Year Return

MAP.AX

47.02%

S&P/ASX 200 [XJO] (^AXJO)

15.60%

5-Year Return

MAP.AX

59.06%

S&P/ASX 200 [XJO] (^AXJO)

52.68%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MAP.AX

Microba Life Sciences Limited

0.1700

+3.03%

Mkt Cap AUD 76.135M